Xie et al. [12] found that P53 inhibits erastin-induced ferroptosis in CRC cells by blocking the activity of dipeptidyl-peptidase-4 (DPP4), which was different from the previously discovered role of P53 in promoting ferroptosis in other cancer cells [13]. Here, TP53 is linked to colorectal carcinoma.